Ocelot Bio, Inc. — Form D
Ocelot Bio, Inc. of San Diego, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-07-13. The offering totals $12.0M, of which $3.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2023-07-13
- Form: D
- Accession: 0001567619-23-006568
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $12.0M
- Amount sold: $3.0M
- Remaining: $9.0M
- Investors: 5
- Date of first sale: 2023-07-06
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-486726
Issuer
- Name: Ocelot Bio, Inc.
- CIK: 0001856030
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 12670 High Bluff Drive, San Diego, CA, 92130
- Phone: (858) 247-2272
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Jack Nielsen | Director | Palo Alto, CA |
| Camille Samuels | Director | South San Francisco, CA |
| Donald Santel | Director | San Diego, CA |
| Jennifer Schranz | Director | San Diego, CA |
| Katherine Stultz | Director | San Diego, CA |
| Katherine Stultz | Executive Officer | San Diego, CA |
| Geoffrey Harris | Director | Iowa City, IA |
| Geoffrey Harris | Executive Officer | Iowa City, IA |
Other filings by this issuer (1)
More